Cannabidivarin (CBDV) Research Dashboard
Double-blind human trials
Clinical human trials
What am I missing as a non-subscriber?
To see a full dashboard with study details and filtering, go to our DEMO page.
As a subscriber, you will be able to access dashboard insights including chemotype overviews and dosing summaries for medical conditions and organ system and receptor breakdowns for cannabinoid and terpene searches. Study lists present important guidance including dosing and chemotype information with the ability to drill down to the published material. And all outputs are fully filterable, to help find just the information you need. Stay up-to-date with the science of cannabis and the endocannabinoid system with CannaKeys.
CannaKeys has 27 studies associated with Cannabidivarin (CBDV).
Here is a small sampling of Cannabidivarin (CBDV) studies by title:
- Cannabinoids: Therapeutic Use in Clinical Practice
- Fetal Exposure to Cannabis and Childhood Metabolic Outcomes: The Healthy Start Study
- Efficacy and safety of cannabidivarin treatment of epilepsy in girls with Rett syndrome: A phase 1 clinical trial
- Effects of rich cannabidiol oil on behavioral disturbances in patients with dementia: A placebo controlled randomized clinical trial
- Modulation of striatal functional connectivity differences in adults with and without autism spectrum disorder in a single-dose randomized trial of cannabidivarin
Components of the Cannabidivarin (CBDV) Research Dashboard
- Top medical conditions associated with Cannabidivarin (CBDV)
- Proven effects in clinical trials for Cannabidivarin (CBDV)
- Receptors associated with Cannabidivarin (CBDV)
- Individual study details for Cannabidivarin (CBDV)
Ready to become a subscriber? Go to our PRICING page.
Members can filter by the following criteria:
- Study Type
- Organ Systems
- Study Result
- Year of Publication
Overview - Cannabidivarin (CBDV)
Description of Cannabidivarin (CBDV)
CBDV was discovered in 1969. It belongs to the CBD family of phytocannabinoids and it shares several characteristics such as being non-psychoactive (i.e., there are no cognitive changes associated with it). CBDV occurs naturally in cannabis and has been gaining attention in the research community for its therapeutic potential relevant to numerous chronic patient populations such as those challenged by epilepsy, inflammation, and chronic pains for example. Typically higher contents of CBDV are found in strains abundant in CBD.
Cannabidivarol, CBDV, CBD-V
IUPAC Name: 2-[(1R,6R)-3-methyl-6-prop-1-en-2-ylcyclohex-2-en-1-yl]-5-propylbenzene-1,3-diol
Molecular Formula: C19H26O2
Cannabidivarin (CBDV) Properties and Effects
Cannabidivarin (CBDV) Receptor Binding
Endocannabinoid System (ECS)
Disclaimers: Information on this site is provided for informational purposes only and is not meant to substitute for the advice provided by your own physician or other medical professional. You should not use the information contained herein for diagnosing a health problem or disease. If using a product, you should read carefully all product packaging. If you have or suspect that you have a medical problem, promptly contact your health care provider.
Information on this site is based on scientific studies (human, animal, or in vitro), clinical experience, or traditional usage as cited in each article. The results reported may not necessarily occur in all individuals. For many of the conditions discussed, treatment with prescription or over-the-counter medication is also available. Consult your physician, nutritionally oriented health care practitioner, and/or pharmacist for any health problem and before using any supplements or before making any changes in prescribed medications.